[Federal Register: January 28, 1999 (Volume 64, Number 18)] [Notices] [Page 4455-4456] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr28ja99-94] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of the National Cancer Advisory Board. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Advisory Board. Date: February 8-10, 1999. Name of Committee: National Cancer Advisory Board, Subcommittee on Cancer Centers. Open: February 8, 1999, 7:00 pm to 8:30 pm. Agenda: To discuss NCI Cancer Centers policies. Place: The Hyatt Regency Hotel, 100 Bethesda Metro Center, Susquehana Severn Room, Bethesda, MD 20892. Contact Person: Brian Kimes, Executive Secretary, Office of Centers, Training, and Resources, National Cancer Institute, National Institutes of Health, Executive Plaza North--Suite 502, 6130 Executive Boulevard, Rockville, MD 20892, (301) 496-8537. Name of Committee: National Cancer Advisory Board, Subcommittee on Planning and Budget. Open: February 9, 1999, 12:10 pm to 1:30 pm. Agenda: To discuss the current and future initiatives of the NCI Bypass Budget. Place: Building 31, C Wing, 6 Floor, Conference Room 10, National Institutes of Health, 3100 Center Drive, Bethesda, MD 20892. Contact Person: Ms. Cherie Nichols, Executive Secretary, Office of Science Policy, National Cancer Institute, National Institutes of Health, Building 31, Room 11A03, 3100 Center Drive, Bethesda, MD 20892, (301) 496 -5515. Name of Committee: National Cancer Advisory Board. Open: February 9, 1999, 9:00 am to 4:00 pm. Agenda: Introductions and Welcome to New Members; Reports from NCI Director, President's Cancer Panel, American Association for Cancer Research, A110 and FOIA; Annual Delegation of Authority; Update on Geographic Patterns of Cancer Mortality in the U.S.; Legislative Update, and Cancer Surveillance Series Surveillance Implementation Group Report. Place: Building 31, C Wing, 6 Floor, Conference Room 10, National Institutes of Health, 3100 Center Drive, Bethesda, MD 20892. Closed: February 9, 1999, 4:15 pm to Adjournment. Agenda: To review and discuss grant applications. Place: Building 31, C Wing, 6 Floor, Conference Room 10, National Institutes of Health, 3100 Center Drive, Bethesda, MD 20892. Open: February 10, 1999, 9:00 am to 12:05 pm. Agenda: Annual Report on Gender and Minority Accrual to Clinical Trials; Update on Programs for Underserved Populations; Office of Cancer Complimentary and Alternative Medicine; Subcommittee Reports, New Business; and Future Agenda Items. Place: Building 31, C Wing, 6 Floor, Conference Room 10, National Institutes of Health, 3100 Center Drive, Bethesda, MD 20892. Contact Person: Marvin R. Kalt, Executive Secretary, Division of Extramural Activities, National Cancer Institute, National Institutes of Health, Executive Plaza North, Suite 600, 6130 Executive Boulevard, Rockville, MD 20892, (301) 496-5147. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) [[Page 4456]] Dated: January 22, 1999. LaVerne Y. Stringfield, Committee Management Officer, NIH. [FR Doc. 99-1965 Filed 1-27-99; 8:45 am] BILLING CODE 4140-01-M